Observing patients with certain blood disorders in Brest
Observatoire Brestois Des Néoplasies Myéloprolifératives
This study is looking at patients with certain blood disorders to gather information about their health and treatment over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Sex | All |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 1 site (Brest) |
| Trial ID | NCT02897297 on ClinicalTrials.gov |
What this trial studies
This observational study includes all patients diagnosed or followed at Brest University Hospital for Philadelphia negative myeloproliferative neoplasms, specifically polycythemia vera, essential thrombocythemia, and primary myelofibrosis. It aims to collect both clinical and biological data from diagnosis until the last known status of the patients. Data will include patient characteristics, disease status, treatment changes, thrombotic events, and mortality details. Patients will be followed until they are lost to follow-up or pass away, with consent required for participation.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with essential thrombocythemia, polycythemia vera, or primary myelofibrosis who can provide consent.
Not a fit: Patients with other types of myeloproliferative neoplasms or those who do not meet the inclusion criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of myeloproliferative neoplasms and improve patient management strategies.
How similar studies have performed: While observational studies on myeloproliferative neoplasms exist, this specific approach in Brest is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with essentiel thrombocythemia, polycythemia vera or primary myelofibrosis * Signature of the non-opposition consent form Exclusion Criteria: * None
Where this trial is running
Brest
- CHRU de Brest — Brest, France (Recruiting)
Study contacts
- Study coordinator: Jean-Christophe Ianotto
- Email: jean-christophe.Ianotto@chu-brest.fr
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.